摘要
小细胞肺癌是一种致死率较高的恶性肿瘤,现阶段的治疗方式有手术,化疗和放疗,但预后极差。近些年来涌现的靶向治疗和免疫治疗也都在进行着大量的临床试验,本文将对小细胞肺癌目前的治疗策略以及未来研究的方向进行综述。
Small cell lung cancer（SCLC） is a malignant tumor with a very high mortality rate. The current standard of care includes surgery, chemotherapy and radiotherapy. The clinical benefit of therapies was disappointing. Recently, many clinical trials about target therapy and immunotherapy are processing. This review will focus on current therapy and future research direction of SCLC.
出处
《中国肺癌杂志》
CAS
CSCD
北大核心
2017年第6期421-426,共6页
Chinese Journal of Lung Cancer
关键词
肺肿瘤
手术
化疗
放疗
靶向治疗
免疫治疗
Lung neoplasms
Surgery
Chemotherapy
Radiotherapy
Target therapy
Immunotherapy
